ClinicalTrials.gg
Not yet recruitingNCT07728786Updated Jul 27, 2026

Outdoor vs. Indoor Exercises and Cognitive Functions in Older Adults

An observational study in Exercise Environment and Cognitive Performance in Older Adults, sponsored by Muğla Sıtkı Koçman University. Not yet recruiting. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-27.

Sponsored by Muğla Sıtkı Koçman University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
100
Ages
60 Years and older
Sex
All
01

Study summary

This observational, cross-sectional study aims to comparatively investigate the effects of outdoor versus indoor exercise environments on overall cognitive performance and its specific sub-domains (attention, memory, and executive functions) in older adults with similar physical capacities. Utilizing a 2 (Exercise Environment: Outdoor vs. Indoor) x 2 (Center: Köyceğiz vs. Erzurum Tazelenme University) factorial design, a sample of 100-120 participants aged 60 and over will be recruited via purposive sampling. To ensure sample homogeneity regarding functional capacity, participants will undergo pre-screening with the 6-Minute Walk Test (6MWT) and the 30-Second Chair Stand Test, while individuals with advanced neurological disorders or severe physical impairments will be excluded. Data will be collected through a Sociodemographic Information Form, the Physical Activity Scale for the Elderly (PASE) to monitor baseline activity parameters, and the Addenbrooke's Cognitive Examination (ACE-III) Turkish Version A to assess cognitive outcomes. Ultimately, this study aims to elucidate the potential predictive role of the exercise environment on cognitive health in late life and explore whether the cognitive benefits of physical activity vary interactively across different geographic centers.

Read the detailed description

This observational, cross-sectional study is designed with a comprehensive quality assurance and operational framework to rigorously investigate the impact of exercise environments on cognitive health in older adults. To ensure data integrity and minimize transcription errors, a multi-stage quality control protocol will be enforced, including double-data entry by two independent investigators and automated database range checks for score boundaries (e.g., restricting the total score of Addenbrooke's Cognitive Examination [ACE-III] between 0 and 100, and validating the age threshold as ≥ 60). Source data verification will be conducted by cross-referencing self-reported chronic conditions and pharmacological backgrounds with institutional health registries where applicable. Operationally, the study follows a strict six-stage Standard Operating Procedure (SOP). Potential participants from Köyceğiz and Erzurum Tazelenme Universities will first undergo a face-to-face pre-screening via a structured Participant Eligibility Form to confirm inclusion criteria, which mandate being aged 60 or older, participating in regular physical exercise, and possessing sufficient sensory and cognitive capacity to complete behavioral testing, while excluding individuals with advanced neurological disorders such as dementia.Following informed consent, participants' functional baseline homogeneity will be verified through validated physical performance metrics, specifically the 6-Minute Walk Test (6MWT) for cardiovascular endurance and the 30-Second Chair Stand Test for lower extremity muscle strength. Based on their primary exercise habits, participants will be classified into the primary independent variables: outdoor or indoor exercise environments. Subsequently, cognitive outcomes across domains of attention, memory, verbal fluency, language, and visuospatial skills will be assessed individually in a controlled, distraction-free environment using the ACE-III Turkish Version A, while past-week physical activity levels will be quantified using the Physical Activity Scale for the Elderly (PASE). Missing data will be managed strictly; variables with less than 15% missing items will be handled via sub-domain mean imputation, whereas cases exceeding this threshold or missing primary cognitive components will be excluded via listwise deletion. Statistical analyses will be executed using IBM SPSS Statistics, utilizing independent samples t-tests or non-parametric Mann-Whitney U tests depending on normality distributions evaluated via Kolmogorov-Smirnov and Shapiro-Wilk criteria. Ultimately, Pearson or Spearman correlation coefficients will assess the relationship between exercise parameters and cognitive scores, and multiple linear regression or analysis of covariance (ANCOVA) will be deployed to isolate the predictive value of the exercise environment on cognitive performance while strictly controlling for confounding covariates such as age, education, baseline physical activity (PASE), and functional capacities (6MWT and chair stand scores), with significance established at p \< 0.05.

02

Conditions studied

  • Exercise Environment and Cognitive Performance in Older Adults

Keywords

  • Cognitive Dysfunction
  • Healthy Aging
  • Cognitive Performance
  • Green Exercise
03

In context

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

This study's planned enrollment of 100 is below the median of 150 across 1,000 observational studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Muğla Sıtkı Koçman University is the lead sponsor of 115 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of older adults aged 60 and over who are actively enrolled as students at Köyceğiz Tazelenme University and Erzurum Tazelenme University in Türkiye. This population represents a unique cohort of older individuals engaged in lifelong learning and structured active aging programs. To investigate the specific role of the exercise environment on cognitive reserve, the sample will be drawn from this population using purposive sampling, selecting individuals who regularly participate in either structured outdoor or indoor physical activities. The population is structurally characterized by functionally independent older adults who exhibit homogeneous physical baseline capacities-verified via objective clinical performance benchmarks-and are free from advanced neurological or debilitating physical conditions.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Must be aged 60 years or older.
  • Must be currently enrolled as a student at Köyceğiz Tazelenme University or Erzurum Tazelenme University.
  • Must participate regularly in either structured outdoor or indoor physical exercises.
  • Must possess sufficient sensory, visual, hearing, and cognitive capacity to comprehend and complete the behavioral and cognitive tests.
  • Must demonstrate similar and homogenous functional physical capacity as verified by the pre-screening benchmarks of the 6-Minute Walk Test and the 30-Second Chair Stand Test.
  • Must provide written voluntarily.

Exclusion criteria

Exclusion Criteria:

  • Being under the age of 60.
  • Having a clinical diagnosis of an advanced neurological disorder, including dementia or severe cognitive impairment.
  • Having severe acute or chronic physical disabilities, musculoskeletal injuries, or medical conditions that medically prevent or restrict safe exercise participation.
  • Having severe uncorrected sensory (visual or hearing) deficits or cognitive impairments that prevent the comprehension of test instructions or completion of the assessments.
  • Refusing to provide written or wishing to withdraw from the evaluation process.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Outdoor

    This cohort consists of older adults aged 60 and over, enrolled in Tazelenme University, who regularly participate in physical exercises in outdoor environments. Participants in this group maintain similar functional and physical capacities as verified by the 6-Minute Walk Test and the 30-Second Chair Stand Test, and they do not have any advanced neurological or severe physical impairments.

  • Indoor

    This cohort consists of older adults aged 60 and over, enrolled in Tazelenme University, who regularly participate in physical exercises in indoor environments. Participants in this group maintain similar functional and physical capacities as verified by the 6-Minute Walk Test and the 30-Second Chair Stand Test, and they do not have any advanced neurological or severe physical impairments.

06

What researchers measure

Primary outcomes

  1. Overall Cognitive Performance and Sub-domains via ACE-III

    Cognitive functions will be assessed using the Addenbrooke's Cognitive Examination-III (ACE-III) Turkish Version A. The test comprehensively evaluates five cognitive domains: attention, memory, verbal fluency, language, and visuospatial skills. Total scores range from 0 to 100, and sub-domain scores range as follows: Attention (0-18), Memory (0-26), Verbal Fluency (0-14), Language (0-26), and Visuospatial (0-16). Higher total and sub-domain scores indicate better cognitive performance and higher cognitive reserve.

    Time frame: Baseline (Data will be collected during a single cross-sectional assessment session for each participant).

Secondary outcomes

  1. Self-Reported Physical Activity Level via PASE

    Participants' physical activity levels over the past week will be measured using the Physical Activity Scale for the Elderly (PASE). The scale evaluates leisure, household, and occupational physical activities through structured questions. Higher total scores on the scale indicate a higher level of physical activity and engagement in daily life movements.

    Time frame: Baseline (Data will be collected during a single cross-sectional assessment session for each participant).

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Albinet, C. T., Boucard, G., Bouquet, C. A., & Audiffren, M. (2012). Processing speed and executive functions in cognitive aging: How to disentangle their mutual relationship? Brain and Cognition, 79(1), 1-11. https://doi.org/10.1016/j.bandc.2012.02.001 Alcazar, J., Kamper, R. S., Aagaard, P., Haddock, B., Prescott, E., Ara, I., & Suetta, C. (2020). Relation between leg extension power and 30-s sit-to-stand muscle power in older adults: validation and translation to functional performance. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-73395-4 Bautmans, I., Lambert, M., & Mets, T. (2004). The six-minute walk test in community dwelling elderly: Influence of health status. BMC Geriatrics, 4, 1-9. https://doi.org/10.1186/1471-2318-4-6 Biazus-Sehn, L. F., Schuch, F. B., Firth, J., & Stigger, F. de S. (2020). Effects of physical exercise on cognitive function of older adults with mild cognitive impairment: A systematic review and meta-analysis. In Archives of Gerontology and Geriatrics (Vol. 89). Elsevier Ireland Ltd. https://doi.org/10.1016/j.archger.2020.104048 Falck, R. S., Davis, J. C., Best, J. R., Crockett, R. A., & Liu-Ambrose, T. (2019, July 1). Impact of exercise training on physical and cognitive function among older adults: a systematic review and meta-analysis. In Neurobiology of Aging. Elsevier Inc. https://doi.org/10.1016/j.neurobiolaging.2019.03.007 Gallardo-Gómez, D., del Pozo-Cruz, J., Noetel, M., Álvarez-Barbosa, F., Alfonso-Rosa, R. M., & del Pozo Cruz, B. (2022). Optimal dose and type of exercise to improve cognitive function in older adults: A systematic review and bayesian model-based network meta-analysis of RCTs. In Ageing Research Reviews (Vol. 76). Elsevier Ireland Ltd. https://doi.org/10.1016/j.arr.2022.101591 Glisky, E. L., Woolverton, C. B., McVeigh, K. S., & Grilli, M. D. (2022). Episodic Memory and Executive Function Are Differentially Affected by Retests but Similarly Affected by Age in a Longitudinal Study of Normally-Aging

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared publicly to maintain participant confidentiality and strictly protect personal privacy in accordance with the national Personal Data Protection Law (KVKK) and the institutional ethics committee guidelines. Since the data collected includes comprehensive sociodemographic details and physical/cognitive functional health scores of vulnerable older adults, public sharing of raw individual datasets is restricted by the institutional ethical clearance. However, aggregated statistical results and study outcomes will be fully accessible through peer-reviewed academic publications.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Dec 2026, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 16, 2026
First posted
Jul 27, 2026
StartEst.
Sep 1, 2026
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 31, 2026
Last update
Jul 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07728786
Responsible party
Meliha Güçlü Saz (Research Assistant, Muğla Sıtkı Koçman University) — Principal investigator
First posted
Jul 27, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jul 27, 2026

Study contacts

Meliha Güçlü Saz, MSc, PhD Student
Contact
melihaguclu@mu.edu.tr
+905374931504

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion